Browse studies

Find your next paid study

1 recruiting study matching your filters

Phase IB/II of CPX-351 as Maintenance Therapy in AML Patients Ineligible for Bone Marrow Transplantation

This is a phase IB/II study with a 3+3 dose de-escalation study design. Patients will continue maintenance treatment with CPX-351 for 6 cycles on D1 and D3, as…

Acute Myeloid Leukemia (AML) in Remission

Georgetown UniversityNCT04990102